Comparison of the hemodynamic effects of amrinone in patients who required low-to-moderate-dose and high-dose catecholamines after cardiac valve replacement

Critical Care Medicine

Volumn 27, Issue 12, 1999, Pages 2698-2702

  Kunimoto, Fumio ^a,b   Isa, Yukitaka ^a   Ohki, Satoshi ^a   Tsukagoshi, Hiroshi ^a   Yoshikawa, Daisuke ^a   Ishikawa, Susumu ^a   Koyama, Hiroshi ^a   Goto, Fumio ^a  

^a GUNMA UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Amrinone; Cardiac output; Cardiac valve replacement; Dobutamine; Dopamine; Pulmonary artery catheter; Pulmonary artery pressure; Systemic arterial pressure; Vascular resistance

Indexed keywords

AMRINONE; DOBUTAMINE; DOPAMINE;

ADULT; AGED; AORTA VALVE REPLACEMENT; ARTERY CATHETERIZATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HEART FUNCTION; HEART INDEX; HEMODYNAMIC MONITORING; HEMODYNAMICS; HUMAN; INOTROPISM; INTENSIVE CARE UNIT; MEAN ARTERIAL PRESSURE; MITRAL VALVE REPLACEMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PULMONARY ARTERY; RADIAL ARTERY; SYSTEMIC VASCULAR RESISTANCE; VASODILATATION;

EID: 0033401963     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199912000-00016     Document Type: Article

References (15)

1. 1. Swanson DK, Myerowitz PD: Effect of reperfusion temperature and pressure on the functional and metabolic recovery of preserved hearts. J Thorac Cardiovasc Surg 1983; 86:242-251
2. 2. Gold JP, Roberts AJ, Hoover EL, et al: Effects of prolonged aortic cross-clamping with potassium cardioplegia on myocardial contractility in man. Surg Forum 1979; 30:252-254
3. 3. Kaplan JA: Treatment of perioperative left heart failure. In: Cardiac Anesthesia. Third Edition. Kaplan JA (Ed). Philadelphia, WB Saunders, 1993, pp 1066-1069
4. 4. Bristow MR, Ginsburg R, Minobe W, et al: Decreased catecholamine sensitivity and beta-adrenergic receptor density in failing human hearts. N Engl J Med 1982; 307: 205-211
5. 5. Mancini D, LeJemtel T, Sonnenblick E: Intravenous use of amrinone for the treatment of the failing heart. Am J Cardiol 1985; 56: 8B-15B
6. 6. Benotti JR, Grossman W, Braunwald E, et al: Effects of amrinone on myocardial energy metabolism in patients with severe congestive heart failure due to coronary artery disease. Circulation 1980; 62:28-34
7. 7. Taylor SH, Verma SP, Hussain M, et al: Intravenous amrinone in left ventricular failure complicated by acute myocardial infarction. Am J Cardiol 1985; 56:29B-32B
8. 8. Konstam MA, Cohen SR, Weiland DS, et al: Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure. Am J Cardiol 1986; 57:242-248
9. 9. Hines R: The choice of inotropes following cardiopulmonary bypass. Pro: Amrinone is a first-choice inotrope following cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1991; 5:181-183
10. 10. Estafanous FG: The choice of inotropes following cardiopulmonary bypass. Con: Amrinone is not a first-choice inotrope following cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1991; 5:184-186
11. 11. Dupuis JY, Bondy R, Cattran C, et al: Amrinone and dobutamine as primary treatment of low cardiac output syndrome following coronary artery surgery, a comparison of their effects on hemodynamics and outcome. J Cardiothorac Vasc Anesth 1992; 6:542-553
12. 12. Goenen M, Pedemonte O, Baele P, et al: Amrinone in the management of low cardiac output after open heart surgery. Am J Cardiol 1985; 56:33B-38B
13. 13. Ramsay JG, DeJesus JM, Wynands JE, et al: Amrinone before termination of cardiopulmonary bypass: Haemodynamic variables and oxygen utilization in the post bypass period. Can J Anaesth 1992; 39:342-348
14. 14. Hess W, Arnold B, Veit S: The haemodynamic effects of amrinone in patients with mitral stenosis and pulmonary hypertension. Eur Heart J 1986; 7:800-807
15. 15. Deeb GM, Boiling SF: The role of amrinone in potential heart transplant patients with pulmonary hypertension. J Cardiothorac Anesth 1989; 3:33-37